Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia
Dansky, Hayes M., MD, Bloomfield, Daniel, MD, Gibbons, Patrice, MS, Liu, Sherry, MS, Sisk, Christine McCrary, BS, Tribble, Diane, PhD, McKenney, James M., PharmD, Littlejohn, Thomas W., MD, Mitchel, Yale, MD
Published in The American heart journal (01.10.2011)
Published in The American heart journal (01.10.2011)
Get full text
Journal Article
Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib
Cannon, Christopher P., MD, Dansky, Hayes M., MD, Davidson, Michael, MD, Gotto, Antonio M., MD, DPhil, Brinton, Eliot A., MD, Gould, A. Lawrence, PhD, Stepanavage, Michael, MS, Liu, Sherry Xueyu, MS, Shah, Sukrut, RPh, PhD, Rubino, Joseph, MBA, Gibbons, Patrice, MS, Hermanowski-Vosatka, Anne, MD, PhD, Binkowitz, Bruce, PhD, Mitchel, Yale, MD, Barter, Philip, MD, PhD
Published in The American heart journal (01.10.2009)
Published in The American heart journal (01.10.2009)
Get full text
Journal Article